Meticuly CEO shares stage with WIPO Director General, highlighting IP's Role in the growth of 3D Printing for patient specific implant and MedTech

Meticuly’s CEO, Asst. Prof. Dr. Boonrat Lohwongwatana, took the international stage this week at IP Week @ Singapore, contributing to a high-level panel discussion on the critical role of intellectual property in building the businesses of the future, particularly for innovations in medical 3D printing for specialised fields like cranioplasty and Orthognathic Surgery. The event, co-hosted by the Intellectual Property Office of Singapore (IPOS) and the World Intellectual Property Organization (WIPO), is a premier global forum on IP and innovation.

Dr Boonrat was honoured to join the panel, "Value Creation through IP: From Intangible Assets to Strategic Growth," alongside esteemed leaders including Mr. Daren Tang, Director General of WIPO. Ms. Sarah Aboerjaib, CEO of ScansX; and Mr. Ang Yuit, President of Singapore's Association of Small & Medium Enterprises (ASME). The session was moderated by Ms. Wendi Backler, Partner and Director at BCG.

IP as the Bridge from Knowledge to Impact of patient specific implant

The panel addressed how a robust IP strategy is essential for attracting investment and building long-term enterprise value. Sharing his personal journey and Meticuly's story, our CEO emphasised a core belief: "Education opens the doors to opportunities, but it is intellectual property and entrepreneurship that create the bridges to turn knowledge into impact."

He explained how this philosophy was central to commercialising Meticuly's core technology. By building a strong IP portfolio around the entire 3D printing workflow, Meticuly provides life-changing solutions for complex procedures, from cranioplasty to Orthognathic Surgery. This protected innovation in the Patient-Specific Implant has enabled the company to attract investors with confidence and build a sustainable global business.

The discussion affirmed that for deep-tech companies, integrating IP into a long-term strategy is the fundamental driver of growth, allowing innovations like the Patient-Specific Implant to reach patients worldwide.